Company Overview:
FSD Pharma is focused on the development of the highest quality indoor grown, pharmaceutical grade cannabis and on the research and development of novel cannabinoid-based treatments for several central nervous system disorders, including chronic pain, fibromyalgia and irritable bowel syndrome. The Company has 25,000 square feet available for production at its Ontario facility.
FSD Pharma’s facilities sit on 70 acres of land with 40 acres primed for development and an expansion capability of up to 3,896,000 square feet.
FSD Pharma’s wholly-owned subsidiary, FV Pharma, is a licensed producer under the Cannabis Act and Regulations, having received its cultivation license on October 13, 2017. FV Pharma’s vision is to transform its current headquarters in a Kraft plant in Cobourg, Ontario into the largest hydroponic indoor grow facility in the world. FV Pharma intends to cover all aspects of this exciting new industry, including cultivation, legal, processing, manufacturing, extracts and research and development.
[stock_market_chart symbol=”HUGE.CN” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]
Key Share Information:
| Current Share Price | $2.24 |
| Market Capitalization (in Millions) | $3,110.12 |
| Last Quarter (Share Data) | 3/31/2019 |
| Shares Outstanding (in Millions) | 1,388.45 |
| Options (in Millions) | 94.68 |
| Warrants (in Millions) | 109.79 |
| Fully Diluted (in Millions) | 1,592.92 |
| Enterprise Value (in MIllions) | $3,094.52 |
| TTM Revenue | $0.15 |
| TTM Growth Margin % | 0.00% |
| TTM Operating Expenses | $42.92 |
| TTM OCF | -$4.18 |
| P/S TTM | 20,669.67 |
| P/S (Last Quarter Run Rate) | 42,028.71 |
Key Balance Sheet Information (in Millions $CAD):
| CYQ4'16 | CYQ1'17 | CYQ2'17 | CYQ3'17 | CYQ4'17 | CYQ1'18 | CYQ2'18 | CYQ3'18 | CYQ4'18 | CYQ1'19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | $0.01 | $0.03 | $0.02 | $0.02 | $0.01 | $2.20 | $31.70 | $33.79 | $21.13 | $17.11 |
| Biological Assets | $0.15 | $0.25 | ||||||||
| Inventory | $0.00 | $0.14 | ||||||||
| Total Assets | $0.01 | $0.03 | $0.02 | $0.02 | $0.01 | $2.24 | $52.80 | $66.58 | $52.78 | $51.00 |
| Net Tangible Assets | $0.01 | $0.03 | $0.02 | $0.02 | $0.01 | $2.24 | $52.80 | $66.58 | $52.78 | $51.00 |
| Intangibles/Goodwill | ||||||||||
| Total Liabilities | $0.08 | $0.11 | $0.11 | $0.11 | $0.11 | $0.04 | $0.31 | $0.29 | $1.74 | $1.50 |
Key Operating Items (Quarterly in Millions $CAD):
| CYQ4'16 | CYQ1'17 | CYQ2'17 | CYQ3'17 | CYQ4'17 | CYQ1'18 | CYQ2'18 | CYQ3'18 | CYQ4'18 | CYQ1'19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.03 | $0.01 | $0.09 | $0.02 | ||||||
| Change in Fair Value of Biologial Assets | ||||||||||
| Gross Margin | ||||||||||
| Marketing and Sales | ||||||||||
| Investor Relations | $0.00 | 0.91 | 2.80 | $1.07 | ||||||
| Total Operating Expenses | $0.00 | $0.01 | $0.00 | $0.02 | $0.01 | $0.05 | $3.46 | 3.03 | 32.86 | $3.56 |
| Operating Cash Flow (Quarterly) | -$0.01 | -$0.01 | $0.00 | -$0.06 | -$19.01 | 4.75 | -4.17 | $14.24 | ||
| Investing Cash Flow (Quarterly) | $0.00 | $0.00 | $0.00 | $0.00 | -$4.44 | -4.80 | -0.75 | $9.51 | ||
| Financing Cash Flow (Quarterly) | $0.04 | $0.00 | $0.00 | $2.25 | $48.23 | 2.13 | -7.74 | -$44.17 |